Searching News Database: Bare-Metal
HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
HSMN NewsFeed - 5 Jun 2014
Cook Medical Makes Zilver(R) PTX(R) Drug-Eluting Stent Available in Canada
Cook Medical Makes Zilver(R) PTX(R) Drug-Eluting Stent Available in Canada
HSMN NewsFeed - 30 Jan 2013
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
HSMN NewsFeed - 14 May 2012
Boston Scientific Announces CE Mark and European Launch of Innova(TM) Self-expanding Bare-metal Stent System
Boston Scientific Announces CE Mark and European Launch of Innova(TM) Self-expanding Bare-metal Stent System
HSMN NewsFeed - 1 Mar 2012
Cook Medical Receives Japanese Approval to Market Its Zilver(R) PTX(R) Drug-Eluting Stent
Cook Medical Receives Japanese Approval to Market Its Zilver(R) PTX(R) Drug-Eluting Stent
HSMN NewsFeed - 1 Nov 2011
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
HSMN NewsFeed - 5 Oct 2011
Boston Scientific Begins Clinical Trial Enrollment for OMEGA(TM) Platinum Chromium Stent System
Boston Scientific Begins Clinical Trial Enrollment for OMEGA(TM) Platinum Chromium Stent System
HSMN NewsFeed - 7 Mar 2011
Boston Scientific Announces European Approval and Launch of OMEGA Platinum Chromium Stent System
Boston Scientific Announces European Approval and Launch of OMEGA Platinum Chromium Stent System
HSMN NewsFeed - 28 Sep 2010
Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease
Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease
HSMN NewsFeed - 22 Sep 2010
Long-Term Data Show Advantages for TAXUS(R) Liberte(R) Stent in Small Vessels and Long Lesions
Long-Term Data Show Advantages for TAXUS(R) Liberte(R) Stent in Small Vessels and Long Lesions
HSMN NewsFeed - 22 Sep 2010
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
HSMN NewsFeed - 7 Sep 2010
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
HSMN NewsFeed - 31 Aug 2010
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
HSMN NewsFeed - 12 May 2010
Boston Scientific Announces European Approval of Platinum Chromium TAXUS(R) Element(TM) Stent System
Boston Scientific Announces European Approval of Platinum Chromium TAXUS(R) Element(TM) Stent System
HSMN NewsFeed - 15 Feb 2010
Stentys Drug-Eluting Self-Expanding Coronary Stent Shows 4% Restenosis in Complex Lesions
Stentys Drug-Eluting Self-Expanding Coronary Stent Shows 4% Restenosis in Complex Lesions
HSMN NewsFeed - 18 Sep 2009
Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent
Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent
HSMN NewsFeed - 27 May 2009
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
HSMN NewsFeed - 19 May 2009
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
HSMN NewsFeed - 14 May 2009
Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
HSMN NewsFeed - 31 Mar 2009
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
HSMN NewsFeed - 17 Feb 2009
CorNova(R) Expands Management Team with Appointment of Robert Gallahue as Chief Financial Officer
CorNova(R) Expands Management Team with Appointment of Robert Gallahue as Chief Financial Officer
HSMN NewsFeed - 4 Feb 2009
Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
HSMN NewsFeed - 30 Oct 2008
Medtronic to Launch Coronary Stents and Balloon Catheters on Rapid Exchange in United States
Medtronic to Launch Coronary Stents and Balloon Catheters on Rapid Exchange in United States
HSMN NewsFeed - 8 Oct 2008
Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
HSMN NewsFeed - 15 Sep 2008
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
HSMN NewsFeed - 30 Jul 2008
Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor(R) and Cypher(R) Drug-Eluting Stents
Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor(R) and Cypher(R) Drug-Eluting Stents
HSMN NewsFeed - 1 Apr 2008
Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
HSMN NewsFeed - 31 Mar 2008
CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
HSMN NewsFeed - 1 Feb 2008
Medtronic Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System
Medtronic Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System
HSMN NewsFeed - 18 Jan 2008
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
HSMN NewsFeed - 24 Oct 2007
Safety Profile of Medtronic's Endeavor(R) Drug-Eluting Stent Affirmed in Comprehensive Data Analysis
Safety Profile of Medtronic's Endeavor(R) Drug-Eluting Stent Affirmed in Comprehensive Data Analysis
HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
HSMN NewsFeed - 22 Oct 2007
Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
HSMN NewsFeed - 22 Oct 2007
Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
HSMN NewsFeed - 22 Oct 2007
Endeavor Clinical Program Continues to Provide Positive Safety and Efficacy Data
Endeavor Clinical Program Continues to Provide Positive Safety and Efficacy Data
HSMN NewsFeed - 10 Oct 2007
FDA Advisory Committee Recommends Medtronic's Endeavor(R) Drug-Eluting Stent for Approval
FDA Advisory Committee Recommends Medtronic's Endeavor(R) Drug-Eluting Stent for Approval
HSMN NewsFeed - 13 Sep 2007
Largest Study to Date Finds Drug-Eluting Stents and Bare-Metal Stents Yield Similarly Low Mortality Rates
Largest Study to Date Finds Drug-Eluting Stents and Bare-Metal Stents Yield Similarly Low Mortality Rates
HSMN NewsFeed - 5 Sep 2007
TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
HSMN NewsFeed - 29 Aug 2007
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
HSMN NewsFeed - 19 Jul 2007
Boston Scientific Announces First Implant of TAXUS(R) Element(TM) Platinum Chromium Stent
Boston Scientific Announces First Implant of TAXUS(R) Element(TM) Platinum Chromium Stent
HSMN NewsFeed - 22 May 2007
ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
HSMN NewsFeed - 20 Mar 2007
Cordis Corporation to Emphasize Commitment to Interventional Cardiology at ACC.07
Cordis Corporation to Emphasize Commitment to Interventional Cardiology at ACC.07
HSMN NewsFeed - 12 Feb 2007
Boston Scientific Welcomes New England Journal of Medicine Articles on Drug-Eluting Stents
Boston Scientific Welcomes New England Journal of Medicine Articles on Drug-Eluting Stents
HSMN NewsFeed - 5 Feb 2007
Study Favors Drug-Eluting Stents Over Bare-Metal Stents in Key Patient Outcomes
Study Favors Drug-Eluting Stents Over Bare-Metal Stents in Key Patient Outcomes
HSMN NewsFeed - 29 Nov 2006
Cleveland Clinic Analysis Finds Patients With Drug-Eluting Stents Are at Increased Risk for Late Thrombosis
Cleveland Clinic Analysis Finds Patients With Drug-Eluting Stents Are at Increased Risk for Late Thrombosis
HSMN NewsFeed - 14 Nov 2006
Study Favors TAXUS(R) Stent Over Cypher(R) Stent and Bare-Metal Stents in Diabetic Patients
Study Favors TAXUS(R) Stent Over Cypher(R) Stent and Bare-Metal Stents in Diabetic Patients
HSMN NewsFeed - 26 Oct 2006
TAXUS(R) stents demonstrate excellent efficacy and safety in studies presented at TCT 2006
TAXUS(R) stents demonstrate excellent efficacy and safety in studies presented at TCT 2006
HSMN NewsFeed - 6 Sep 2006
TAXUS II Clinical Trial Follow-Up Data Demonstrates Excellent Long-Term Outcomes at Four Years
TAXUS II Clinical Trial Follow-Up Data Demonstrates Excellent Long-Term Outcomes at Four Years
HSMN NewsFeed - 17 May 2006
TAXUS(R) coronary stent system cited by EuroIntervention for superiority in diabetic patients
TAXUS(R) coronary stent system cited by EuroIntervention for superiority in diabetic patients
HSMN NewsFeed - 17 May 2006
TAXUS(R) Coronary Stent System Cited by EuroIntervention for Superiority in Diabetic Patients
TAXUS(R) Coronary Stent System Cited by EuroIntervention for Superiority in Diabetic Patients
HSMN NewsFeed - 16 May 2006
X-Cell Medical Completes Enrollment for Clinical Trial of ETHOS II Estradiol Eluting Stent
X-Cell Medical Completes Enrollment for Clinical Trial of ETHOS II Estradiol Eluting Stent
Additional items found! 48
Members Archive contains
48 additional stories matching:
Bare-Metal
(Password required)
Bare-Metal
(Password required)